false 0001595248 0001595248 2023-09-08 2023-09-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
   
 
 
FORM 8-K 
    
 
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
September 8, 2023
Date of report (Date of earliest event reported)
 
GENPREX, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
001-38244
90-0772347
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. Employer
Identification Number)
     
3300 Bee Cave Road, #650-227, Austin, TX
 
78746
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (512) 537-7997
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.001 per share
 
GNPX
 
The Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
 
 

 
 
Item 7.01 Other Events.
 
Corporate Presentation
 
The investor presentation about Genprex, Inc. (the “Company”) that is furnished as Exhibit 99.1 to this Current Report on Form 8-K may be presented at meetings with investors, analysts, and others, in whole or in part and possibly with modifications, from time to time on or after September 8, 2023. A copy of the investor presentation slides, substantially in the form expected to be used in such presentations and meetings, will be available on the Company’s website, www.genprex.com.
 
The information in this Current Report on Form 8-K under Item 7.01, including the information contained in Exhibit 99.1, is being furnished to the Securities and Exchange Commission, and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by a specific reference in such filing.
 
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit
Number
 
 Description
     
99.1   Investor Presentation
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
 

 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
GENPREX, INC.
 
       
Date: September 8, 2023
By:
/s/ Ryan Confer
 
   
Ryan Confer
 
   
Chief Financial Officer
(Principal Financial Officer)
 
 
 

Exhibit 99.1

 

 

slide01.jpg
 
 

 
slide02.jpg

 

 

 
slide03.jpg

 

 

 
slide04.jpg

 

 

 
slide05.jpg

 

 

 
slide06.jpg

 

 

 
slide07.jpg

 

 

 
slide08.jpg

 

 

 
slide09.jpg

 

 

 
slide10.jpg

 

 

 
slide11.jpg

 

 

 
slide12.jpg

 

 

 
slide13.jpg

 

 

 
slide14.jpg

 

 

 
slide15.jpg

 

 

 
slide16.jpg

 

 

 
slide17.jpg

 

 

 
slide18.jpg

 

 

 
slide19.jpg

 

 

 
slide20.jpg

 

 

 
slide21.jpg

 

 

 
slide22.jpg

 

 

 
slide23.jpg

 

 

 
slide24.jpg

 

 

 
slide25.jpg

 

 

 
slide26.jpg

 

 

 
slide27.jpg

 

 

 
slide28.jpg

 

 

 
slide29.jpg

 

 

 
slide30.jpg

 

 

 
slide31.jpg

 

 

 
slide32.jpg

 

 

 
slide33.jpg

 

 

 
slide34.jpg

 

 

 
slide35.jpg

 

 

 
slide36.jpg

 

 

 
slide37.jpg

 

 

 
slide38.jpg

 

 

 
slide39.jpg

 

 

 
slide40.jpg

 

 

 
slide41.jpg

 

 

 
slide42.jpg

 

 

 
slide43.jpg

 

 

 
slide44.jpg

 

 

 
slide45.jpg

 

 

 
slide46.jpg

 

 

 
slide47.jpg

 

 

 
slide48.jpg

 

 

 
slide49.jpg

 

 

 
slide50.jpg

 

 

 
slide51.jpg

 

 

 
slide52.jpg

 

 
v3.23.2
Document And Entity Information
Sep. 08, 2023
Document Information [Line Items]  
Entity, Registrant Name GENPREX, INC.
Document, Type 8-K
Document, Period End Date Sep. 08, 2023
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-38244
Entity, Tax Identification Number 90-0772347
Entity, Address, Address Line One 3300 Bee Cave Road, #650-227
Entity, Address, City or Town Austin
Entity, Address, State or Province TX
Entity, Address, Postal Zip Code 78746
City Area Code 512
Local Phone Number 537-7997
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol GNPX
Security Exchange Name NASDAQ
Entity, Emerging Growth Company true
Entity, Ex Transition Period true
Amendment Flag false
Entity, Central Index Key 0001595248

Genprex (NASDAQ:GNPX)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Genprex 차트를 더 보려면 여기를 클릭.
Genprex (NASDAQ:GNPX)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Genprex 차트를 더 보려면 여기를 클릭.